CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Accounts receivable - net of allowance for credit losses | $ 296 | $ 318 |
| Common Stock, No Par Value | $ 0 | $ 0 |
| Common Stock, Shares Authorized | 99,999,999 | 99,999,999 |
| Common Stock, Shares, Issued | 50,773,337 | 48,923,903 |
| Common Stock, Shares, Outstanding | 50,773,337 | 48,923,903 |
| Founder Share, No Par Value | $ 0 | $ 0 |
| Founder Shares, Authorized | 1 | 1 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Statement of Comprehensive Income [Abstract] | |||
| Net income (loss) | $ 32,372 | $ (1,877) | $ (136,867) |
| Change in unrealized gains (losses) on marketable securities: | |||
| Unrealized gains arising during the period, net of tax | (207) | 0 | 0 |
| Losses (gains) reclassified into earnings, net of tax | 0 | 0 | 0 |
| Change in unrealized gains (losses) on cash flow hedges: | |||
| Unrealized gains (losses) arising during the period | (961) | 4,273 | (11,386) |
| Losses (gains) reclassified into earnings, net of tax | (5,861) | 8,741 | 7,582 |
| Net current-period other comprehensive income (loss) | (6,615) | 13,014 | (3,804) |
| Comprehensive income (loss) | $ 25,757 | $ 11,137 | $ (140,671) |
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Statement of Stockholders' Equity [Abstract] | ||
| Unrealized gains on derivatives | $ 2,982 | $ 9,804 |
| Unrealized gains on marketable securities | $ 207 | $ 0 |
| Fair market value of shares | 68,000 | |
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||
| Net income (loss) | $ 32,372 | $ (1,877) | $ (136,867) |
| Adjustments to reconcile net income (loss) to cash provided by operating activities: | |||
| Depreciation and amortization | 11,858 | 9,023 | 8,567 |
| Loss from sale of property and equipment | 576 | 0 | 0 |
| Share-based compensation | 129,209 | 100,186 | 104,920 |
| Charitable share contribution to Foundation | 17,908 | 0 | 0 |
| Amortization of discount and accretion of interest on marketable securities | (227) | 0 | 0 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable, net | (7,893) | (4,685) | (4,717) |
| Prepaid expenses and other assets | 16,280 | 11,840 | 6,490 |
| Accounts payable | 10,406 | 17,397 | (16,072) |
| Accrued expenses and other liabilities | 27,459 | 14,588 | 326 |
| Deferred revenue | 73,117 | 68,932 | 64,491 |
| Net cash provided by operating activities | 311,065 | 215,404 | 27,138 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||
| Purchase of property and equipment | (13,211) | (7,901) | (16,003) |
| Purchase of marketable securities | (49,570) | 0 | 0 |
| Investments in affiliated company | (6,000) | 0 | 0 |
| Capitalized software development costs | (2,024) | (2,558) | (2,998) |
| Net cash used in investing activities | (70,805) | (10,459) | (19,001) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||
| Proceeds from exercise of share options and employee share purchase plan | 43,341 | 21,243 | 12,181 |
| Receipt (repayment) of tax advance relating to exercises of share options and RSUs, net | 11,873 | 4,046 | (21,152) |
| Capital lease payments | 0 | 0 | (84) |
| Net cash provided by (used in) financing activities | 55,214 | 25,289 | (9,055) |
| INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS | 295,474 | 230,234 | (918) |
| CASH, CASH EQUIVALENTS – Beginning of year | 1,116,128 | 885,894 | 886,812 |
| CASH, CASH EQUIVALENTS – End of year | 1,411,602 | 1,116,128 | 885,894 |
| SUPPLEMENTAL DISCLOSURE: | |||
| Cash paid for taxes | 6,210 | 7,560 | 5,909 |
| Cash paid for interest | 0 | 25 | 62 |
| NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||
| Non-cash purchases of property and equipment | 368 | 105 | 205 |
| Capitalized share-based compensation costs | 1,144 | 1,997 | 1,934 |
| Right-of-use asset recognized with corresponding lease liability | $ 68,743 | $ 93 | $ 97,289 |
ORGANIZATION AND DESCRIPTION OF BUSINESS |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| ORGANIZATION AND DESCRIPTION OF BUSINESS |
NOTE 1: ORGANIZATION AND DESCRIPTION OF BUSINESS
monday.com Ltd (“monday.com” and together with its subsidiaries collectively, “the Company”) was incorporated under the laws of Israel and commenced operations in 2012. The Company operates a cloud-based visual Work Operating System (‘Work OS’) that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. By using the Company’s Work OS platform and product suite, customers can simplify and accelerate their digital transformation, enhance organizational agility, create a unifying workspace across departments, and increase operational efficiency and productivity.
monday.com has nine wholly owned subsidiaries: monday.com Inc. (the “U.S. Subsidiary”), incorporated in the United States in 2016, monday.com UK 2020 LTD., incorporated under the laws of England in 2020, monday.com PTY., incorporated in Australia in 2020, monday.com LTDA., incorporated in Brazil in 2021, monday.com K.K., incorporated in Japan in 2021, monday.com Sp.z o.o., incorporated in Poland in 2022, monday.com PTE., incorporated in Singapore in 2022, monday.com SAS., incorporated in France in 2024, and monday.com GmbH., incorporated in Germany in 2024. The subsidiaries primarily engage in providing business development, presale, and customer success services to the Company’s existing and potential customers. |
SIGNIFICANT ACCOUNTING POLICIES |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SIGNIFICANT ACCOUNTING POLICIES |
NOTE 2: SIGNIFICANT ACCOUNTING POLICIES
The accompanying consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), reflect the application of the significant accounting policies described below and elsewhere in the notes to the consolidated financial statements.
The accompanying consolidated financial statements include the accounts of monday.com and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
The Company bases its estimates on historical experience and on assumptions that management considers to be reasonable.
The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates.
The Company’s management has determined that the United States dollar is the currency in the primary economic environment in which monday.com and its subsidiaries operate. Thus, the Company reports its consolidated results in United States dollars. Transactions and balances that are denominated in other currencies have been remeasured into United States dollars in accordance with principles set forth in Accounting Standards Codification (“ASC”) Topic 830, “Foreign Currency Matters” (“ASC 830”).
At the end of each reporting period, financial assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-financial assets and liabilities are remeasured at historical exchange rates. Gains and losses related to remeasurement are recorded as financial income, net in the consolidated statements of operations as appropriate.
The Company classifies all unrestricted highly liquid investments with maturities of three months or less at the date of purchase as cash equivalents. Cash equivalents consist of bank deposits and money market funds.
The Company accounts for investments in marketable securities in accordance with ASC Topic 320, “Investments - Debt Securities” (“ASC 320”). Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determinations at each balance sheet date. The Company classifies all of its debt securities as available-for-sale (“AFS”) as the Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its marketable securities within current assets on the consolidated balance sheet.
Available-for-sale debt securities are carried at fair value, with the unrealized gains and losses, net of tax, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses on sale of investments are included in financial income, net and are derived using the specific identification method for determining the cost of securities sold.
The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity.
Such amortization together with accretion of interest on securities is included in financial income, net. At each reporting period, the Company evaluates whether declines in fair value below amortized cost are due to expected credit losses, as well as the company’s ability and intent to hold the investment until a forecasted recovery occurs in accordance with ASC Topic 326, “Financial Instrument- Credit losses” (“ASC 326”). Allowance for credit losses on AFS debt securities is recognized in the Company’s consolidated statements of operations, and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in shareholders’ equity. No credit losses were recognized during the year ended December 31, 2024.
Accounts receivable are recorded at the invoiced amount, are unsecured and do not bear interest. The Company maintains an allowance for credit losses inherent in its accounts receivable including potential uncollectible amounts.
The allowance is based on the Company’s periodic assessment of the collectability of the accounts based on a combination of factors including the payment terms of each account, its age, the collection history of each customer, and the customer’s financial condition.
Expenses associated with credit losses for the years ended December 31, 2024, 2023 and 2022 were $2,525, $2,040 and $1,622, respectively. The Company wrote off bad debts in the amount of $2,547, $2,130 and $1,463 during 2024, 2023 and 2022, respectively.
The Company accounts for an equity method investment over which it has significant influence but does not own a majority of the equity interests or otherwise controls and the investment is either in common stock or in substance common stock using the equity method, in accordance with ASC Topic 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”). The Company’s share of the investee’s profit and loss is recognized in the consolidated statements of operations.
Management’s judgment regarding the level of influence over its equity method investee includes considering key factors such as the Company’s ownership interest, representation on the board of directors, participation in policy-making decisions and material intercompany transactions.
The Company assesses its equity method investment for other-than-temporary impairment by considering factors as well as all relevant and available information including, but not limited to, current economic and market conditions, the operating performance of the affiliated company, including current earnings trends, and other affiliated company-specific information such as financing rounds. During 2024, no impairment loss was recognized in the Company’s consolidated statement of operations.
The net carrying value of the investment in the affiliated company amounted to $6,000 as of December 31, 2024 and is presented as part of other-long term assets in the consolidated balance sheet. There were no investments in affiliated companies in 2023. Equity gains (losses) were immaterial in 2024.
Property and equipment, net is stated at cost, less accumulated depreciation and amortization. Depreciation is computed on a straight-line basis over the estimated useful lives of the related assets (see Note 2j). Expenditures for maintenance and repairs are expensed as incurred. Disposals are removed at cost less accumulated depreciation and any gain or loss from disposals is reflected in the consolidated statement of operations in the period of disposition.
The Company capitalizes certain internal use software development costs related to its cloud-based platform (amortized over 3 years) or to back-office operating systems (amortized over six years). The costs consist of personnel costs incurred during the application development stage. Capitalization begins when the preliminary project stage is completed, and it is probable that the software will be completed and used for its intended function.
Capitalization ceases when the software is substantially complete and ready for its intended use, including the completion of all significant testing. Costs related to preliminary project activities and post implementation operating activities are expensed as incurred.
Capitalized software development costs are included in property and equipment, net in the consolidated balance sheet (see Note 5) and are amortized over the estimated useful life of the software, on a straight-line basis, which represents the manner in which the expected benefit will be derived. Amortization expenses are included in cost of revenue in the consolidated statement of operations. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets.
Long-lived assets with definite lives consist of property and equipment. Long-lived assets are amortized over their estimated useful lives which are as follows:
The Company reviews its long-lived assets for impairment whenever events or circumstances have occurred that indicate that the estimated useful lives of the long-lived assets may warrant revision or that the carrying value of these assets may be impaired. To compute whether assets have been impaired, the estimated undiscounted future cash flows of the assets or asset group are compared to the carrying value. If the undiscounted future cash flows are less than the carrying value, an impairment loss is recognized based on the amount in which the carrying amount exceeds the fair value of the asset or asset group, based on discounted cash flows. There were no events or circumstances that required the Company’s long-lived assets to be tested for impairment during any of the periods presented.
The Company accounts for its leases in accordance with ASC Topic 842, “Leases” (“ASC 842”). The Company determines if an arrangement is a lease at inception by determining if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration and other facts and circumstances.
The Company classifies leases at their inception as either capital or operating leases. A lease that transfers substantially all the risks and rewards incidental to ownership of the leased asset to the Company is classified as a capital lease. For capital leases, at the commencement of the lease term, the leased asset is measured at the lower of fair value or the present value of the minimum lease payments. The leased asset is depreciated over the shorter of its useful life and the lease term.
For operating leases, right-of-use (“ROU”) assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company’s leases do not provide an implicit rate, the Company uses the incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company’s understanding of what its credit rating would be. The ROU assets also include any lease payments made prior to commencement and are recorded net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the consolidated statements of operations and are not included in the operating lease ROU assets and lease liabilities. Certain lease agreements include rental payments adjusted periodically for the consumer price index (“CPI”). The ROU assets and lease liabilities were calculated using the initial CPI and will not be subsequently adjusted.
The Company’s lease agreements generally do not contain any residual value guarantees, restrictions, or covenants.
For operating leases that contain renewals, or other lease incentives, the Company recognizes the rent expense on a straight-line basis over the term of the lease. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.
The Company utilized the practical expedient in ASC 842 and elected not to record leases with an initial term of 12 months or less on the balance sheet. Therefore, for short-term leases with a term of 12 months or less, operating lease ROU assets and lease liabilities are not recognized, and the Company records such lease payments in the consolidated statements of operations on a straight-line basis over the lease term.
Rent expenses for the years ended December 31, 2024, 2023 and 2022, were $27,038, $21,369, and $16,396, respectively. See also Note 9.
According to the Israeli Severance Pay Law, 1963 (“Severance Pay Law”), employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one-month salary for each year of employment, or a portion thereof. The Company’s liability for severance pay is covered by the provisions of Section 14 of the Severance Pay Law (“Section 14”).
Under Section 14 employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, contributed on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. Therefore, the Company does not recognize a liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company’s consolidated balance sheet. Severance expenses for the years ended December 31, 2024, 2023 and 2022, amounted to $11,086, $8,435 and $7,289, respectively.
The Company’s U.S. Subsidiary has a 401(K) defined contribution plan covering certain employees in the U.S. All eligible employees may elect to contribute up to 100% of their annual compensation to the plan through salary deferrals, subject to Internal Revenue Service limits. The expenses recorded by the U.S. subsidiary for employer’s contributions were $2,493, $1,898 and $1,551 for the years ended December 31, 2024, 2023 and 2022, respectively.
The Company accounts for its contingent liabilities in accordance with ASC Topic 450, “Contingencies” (“ASC 450”). A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.
With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter.
The Company generates revenue from the sale of subscriptions to customers to access its cloud-based Work OS platform. The terms of the Company’s subscription agreements are primarily monthly or annual, and a large portion of the arrangements are paid in full up-front at the outset of the arrangement. Customers may not take possession over the software and instead are granted continuous access to the platform over the contractual period and therefore the arrangements are accounted for as service contracts.
The Company’s contracts generally include fixed number of users and fixed price per user. Revenue for these arrangements is recognized ratably over the contract term.
The Company’s subscription contracts are generally non-cancelable except for contracts with first-time customers whereby the contract terms provide rights to cancel the contract in the first 30 days for pro-rated refund for unutilized days. Historically, refunds have not been material, and therefore no provision for refunds was recorded to date.
In accordance with ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”), revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration the Company expects to be entitled to receive in exchange for these services.
The Company determines revenue recognition through the following steps:
The Company considers the terms and conditions of the contracts and the Company’s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party’s rights regarding the services to be transferred and the payment terms for the services, it has determined the customer to have the ability and intent to pay, and the contract has commercial substance.
The Company applies certain judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s payment history or, in the case of a new customer, credit and financial information pertaining to the customer.
Performance obligations committed in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services and the products is separately identifiable from other promises in the contract.
The Company’s performance obligations generally consist of access to the cloud-based platform and related support services which is considered one performance obligation.
The customers do not have the ability to take possession of the software, and through access to the platform the Company provides a series of distinct software-based services that are satisfied over the term of the subscription.
The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring services to the customer.
Payment terms are generally upfront at the time of the transaction, except for enterprise customers which are generally net 30 days. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts generally do not include a significant financing component. The Company applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component.
The Company’s policy is to exclude sales and other indirect taxes when measuring the transaction price.
The Company’s contracts contain a single performance obligation. Therefore, the entire transaction price is allocated to the single performance obligation.
Revenue is recognized ratably over the term of the subscription agreement generally beginning on the date that the platform is made available to a customer.
Contract balances
Contract assets consist of unbilled accounts receivable, which occur when a right to consideration for the Company’s performance under the customer contract occurs before invoicing to the customer. The amount of unbilled accounts receivable included within accounts receivable, net on the consolidated balance sheets was immaterial for the periods presented.
Contract liabilities consist of deferred revenues. The Company records contract liabilities when cash payments are received in advance of performance to deferred revenue or to customer advances in case of refund rights.
The Company recognized $266,284, $198,099 and $134,438 of revenue during the years ended December 31, 2024, 2023 and 2022, respectively, that were included in the deferred revenue balance at the beginning of the respective year.
Remaining performance obligations
The Company has elected to apply the practical expedient in ASC 606 and does not disclose the value of unsatisfied performance obligations for unearned revenue since the original expected duration of the majority of the contracts is one year or less.
Contract costs
The Company accounts for costs to obtain revenue contracts in accordance with ASC Topic 340-40, “Other assets and deferred costs” (“ASC 340-40”). Sales commissions earned by external partners and by internal salespersons are considered incremental and recoverable costs of acquiring customer contracts. These costs are capitalized and amortized on a straight-line basis over the anticipated period of benefit, which is estimated to be three years, taking into consideration anticipated contract renewals. The Company determined the period of benefit by taking into consideration historical customer attrition rates, the useful life of the Company’s technology, and other factors.
Deferred contract costs amounted to $20,522 and $3,675 as of December 31, 2024 and 2023, respectively. Amounts expected to be recognized in excess of one year as of the balance sheet date are recorded as other long-term assets, in the consolidated balance sheets.
Deferred contract costs are periodically analyzed for impairment. There were no impairment losses recorded during the periods presented. Amortization is recorded within sales and marketing expense in the consolidated statements of operations. Amortization expenses related to deferred contract costs amounted to $6,382 in 2024, and $0 in each of 2023 and 2022.
The Company has elected to apply the practical expedient allowed by ASC 606 according to which incremental costs of obtaining a contract are recognized as an expense when incurred if the amortization period of the asset is one year or less, and the initial commission rate is commensurate with the commission rate on subsequent renewals.
Cost of revenue primarily consists of costs related to providing subscription services to paying customers, including hosting costs, personnel-related expenses of customer support including share-based compensation, subcontractors costs, merchant and credit-cards processing fees, amortization of capitalized software development costs and allocated overhead costs.
Research and development costs are expensed as incurred unless these costs qualify for capitalization as internal-use software development costs.
Research and development expenses consist primarily of personnel-related expenses, including share-based compensation and allocated overhead costs.
Sales and marketing expenses are primarily comprised of costs of the Company’s marketing personnel including share-based compensation, online marketing expenses and other advertising costs, partners’ commissions and allocated overhead costs. Sales and marketing expenses are expensed as incurred. Advertising costs amounted to $218,415, $203,235 and $181,447, in the years ended December 31, 2024, 2023 and 2022, respectively.
General and administrative expenses primarily consist of personnel-related and share-based compensation expenses associated with the Company’s executives, as well as its finance, legal, human resources and other operational and administrative functions, professional fees for external legal, accounting, and other consulting services, directors and officer’s insurance expenses, donations, charitable contributions to the Monday.com Foundation and allocated overhead costs.
The Company accounts for share-based compensation under ASC Topic 718, Compensation - Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to employees, non-employee consultants and directors, including options, restricted share units (“RSUs”), and shares issued pursuant to the 2021 Employee Share Purchase Plan (“ESPP”) based on the fair value of the awards on the date of grant as follows:
(i) share options – the fair value is based on the Black-Scholes option-pricing model, (ii) RSUs – the fair value is based on the closing trading price of the underlying shares at the date of grant and, (iii) ESPP – the fair value is based on the Monte-Carlo simulation model due to certain limitation on the number of shares per employee.
The expense for share-based compensation cost is recognized over the requisite service period of each individual grant using the graded vesting attribution method for both service-based and performance-based awards. Forfeitures are accounted for as they occur.
The Company granted performance-based awards to its Co-Chief Executive Officers (“Co-CEOs”) and several other members of its senior management. The number of performance-based awards earned and eligible to vest are generally determined after a one-year performance period, based on achievement of certain Company financial performance measures and the recipient’s continued service.
The Company recognizes share-based compensation expense for the performance-based awards using the fair value at the date of grant over the requisite service when it is probable that the performance conditions will be achieved.
The Company adjusts the number of units expected to vest based on estimates of performance against the pre-set objectives.
Valuation assumptions used in measuring compensation costs:
The Black-Scholes option-pricing model requires the Company to make several assumptions, including the value of the Company’s ordinary shares, expected volatility, expected term, risk-free interest rate and expected dividends. The Company evaluates the assumptions used to value option awards upon each grant of share options.
Expected volatility was calculated based on the implied volatilities from market comparisons of certain publicly traded companies. The expected option term was calculated based on the simplified method, which uses the midpoint between the vesting date and the contractual term, as the Company does not have sufficient historical data to develop an estimate based on participant behavior. The risk-free interest rate was based on the U.S. treasury bonds yield with an equivalent term. The Company has not paid dividends and has no foreseeable plans to pay dividends.
The assumptions used to determine the fair value of the share-based awards are management’s best estimates and involve inherent uncertainties and the application of judgment.
The following table summarizes the Black-Scholes assumptions used at the grant dates:
The following table summarizes the Monte-Carlo model assumptions used at the grant dates:
The Company accounts for income taxes in accordance with ASC Topic 740, “Income Taxes” (“ASC 740”), using the liability method whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized. As of December 31, 2024 and 2023, the Company recorded a full valuation allowance against its deferred tax assets.
The Company applies a more-likely-than-not recognition threshold to uncertain tax positions based on the technical merits of the income tax positions taken.
The Company does not recognize a tax benefit unless it is more likely than not that the tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit that is recorded for these positions is measured at the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. As of December 31, 2024 and 2023, no liability for unrecognized tax benefits was recorded due to immateriality.
The Company’s basic net income (loss) per share is calculated by dividing net income (loss) attributable to ordinary shareholders by the weighted-average number of shares of ordinary shares outstanding for the period, without consideration of potentially dilutive securities.
The diluted net income (loss) per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury shares method or the if-converted method based on the nature of such securities.
In periods in which the Company had a net loss, diluted net loss per share was the same as basic net loss per share since the effects of potentially dilutive shares of ordinary shares were anti-dilutive.
The total weighted average number of shares related to the outstanding options and RSUs that were excluded from the calculations of diluted earnings per share, since it would have an anti-dilutive effect, were 135,191 shares, 4,294,853 shares and 4,617,018 shares for 2024, 2023 and 2022, respectively.
The Founder’s share is not a participating security and therefore excluded from the net income (loss) per share.
Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents (including money market funds and bank deposits up to three months), marketable securities and accounts receivable.
For cash and cash equivalents, the Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits. The Company places its cash and cash equivalents with financial institutions with high-quality credit ratings in the United States, Israel, Ireland, Cayman Islands, and Luxembourg and has not experienced any losses in such accounts.
The Company’s marketable securities consist of investments in U.S. government treasury bills. The Company’s investment policy limits the amount that the Company may invest in any one type of investment or issuer, thereby reducing credit risk concentrations.
For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying consolidated balance sheets. For each of the years ended December 31, 2024, and 2023, there were no individual customers that accounted for 10% or more of the Company’s revenues. The Company’s accounts receivable are geographically diversified and derived primarily from sales in the United States, EMEA, and APAC. To manage its accounts receivable risk, the Company evaluates the credit worthiness of its customers and maintains allowances for potential credit losses.
The Company has not historically experienced any material credit losses related to individual customers or groups of customers in any specific area or industry.
W. Segment Information
The Company has a single operating and reportable segment. The Company’s chief operating decision makers are its two Co-Chief Executive Officers (“Co-CEOs”), who review financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources.
For information regarding the Company’s long-lived assets and revenue by geographic area, as well as a summary of significant expense categories, see Note 16.
X. Fair Value measurements
Fair value is defined as the exchange price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company measures financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Three levels of inputs may be used to measure fair value:
The carrying amount of cash and cash equivalents, accounts receivable, prepaid expenses, accounts payable, and accrued expenses, are stated at their carrying value, which approximates fair value due to the short maturities of these instruments.
Assets measured at fair value on a recurring basis as of December 31, 2024 and 2023, are comprised of money market funds, marketable securities, and derivative instruments (see Note 8).
Y. Derivative Financial Instruments
Derivatives are recognized at fair value as either assets or liabilities in the consolidated balance sheets in accordance with ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The gain or loss of derivatives which are designated and qualify as hedging instruments in a cash flow hedge, is recorded under accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Derivatives are classified within Level 2 of the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments.
The Company’s primary objective for holding derivative instruments is to reduce its exposure to foreign currency rate changes. The Company reduces its exposure by entering into forward foreign exchange contracts and option contracts with respect to operating expenses that are forecasted to be incurred in currencies other than the U.S. dollar.
A majority of the Company’s revenues and operating expenditures are transacted in U.S. dollars. However, certain operating expenditures are incurred in or exposed to other currencies, primarily the New Israeli Shekel (“NIS”).
The Company has established forecasted transaction currency risk management programs to protect against fluctuations in fair value and the volatility of future cash flows caused by changes in exchange rates. The Company’s currency risk management program includes foreign exchange contracts designated as cash flow hedges. These foreign exchange contracts generally mature within 12 months (see Note 7).
In addition, occasionally the Company enters into swaps, options and forward contracts to hedge a portion of its monetary items in the balance sheet, such as cash and cash equivalents balances, denominated in other currencies for short-term periods. The purpose of these contracts is to protect the fair value of the monetary assets from foreign exchange rate fluctuations. Gains and losses from derivatives related to these contracts are not designated as hedging instruments. The Company does not enter into derivative financial instruments for trading or speculative purposes.
Z. Recently Adopted Accounting Pronouncements:
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures” (“ASU 2023-07”) to improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses on an interim and annual basis. All disclosure requirements of ASU 2023-07 are also required for entities with a single reportable segment. ASU 2023-07 is effective starting January 1, 2024 and should be applied on a retrospective basis to all periods presented. The adoption of this ASU did not have a material impact on the Company’s financial statements (see also Note 16).
AA. Accounting pronouncements not yet effective
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740) – Improvements to Income Tax Disclosures” (“ASU 2023-09”). The ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as provide additional information for reconciling items that meet a quantitative threshold. Further, the ASU requires certain disclosures of state versus federal income tax expense and taxes paid. The amendments in this ASU are required to be adopted starting January 1, 2025. Early adoption is permitted, and the amendments should be applied on a prospective basis. The Company is currently evaluating the effect of adopting the ASU on its related disclosures.
In November 2024, the FASB issued ASU 2024-03, “Income Statement–Reporting Comprehensive Income–Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), which requires the disaggregation of certain expenses in the financial statements notes, to provide enhanced transparency into the expense captions presented on the face of the consolidated statement of operations. ASU 2024-03 is effective for annual reporting periods beginning January 1, 2027 and interim periods beginning January 1, 2028 and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that ASU 2024-03 will have on its related disclosures, and the transition method. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES |
NOTE 3: CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES
The following is a summary of available-for-sale marketable securities as of December 31, 2024, excluding securities classified within cash and cash equivalents on the consolidated balance sheet:
The Company did not have any marketable securities as of December 31, 2023, except for securities classified within cash and cash equivalents.
As of December 31, 2024, interest receivable on marketable securities amounted to $86 and is included within marketable securities in the consolidated balance sheet. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PREPAID EXPENSES AND OTHER CURRENT ASSETS |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid Expense and Other Assets, Current [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PREPAID EXPENSES AND OTHER CURRENT ASSETS |
NOTE 4: PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets consisted of the following:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
PROPERTY AND EQUIPMENT, NET |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Property, Plant and Equipment [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PROPERTY AND EQUIPMENT, NET |
NOTE 5: PROPERTY AND EQUIPMENT, NET
Depreciation and amortization expense was $11,858, $8,961 and $5,913, for the years ended December 31, 2024, 2023 and 2022, respectively. During the years ended December 31, 2024, 2023 and 2022, the Company recognized capital losses of $576, $62 and $0.
The Company capitalized costs related to the development of internal-use software of $3,013, $4,019 and $4,931 for the years ended December 31, 2024, 2023 and 2022, respectively. Amortization of capitalized software development costs was $3,883, $2,558 and $1,492 for the years ended December 31, 2024, 2023 and 2022, respectively. The net carrying value of capitalized internal-use software was $8,823 and $9,693 as of December 31, 2024 and 2023, respectively. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES |
12 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||
| Accrued Liabilities, Current [Abstract] | ||||||||||||||||||||||||||||||||||||
| ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES |
NOTE 6: ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
|
|||||||||||||||||||||||||||||||||||
DERIVATIVES AND HEDGING |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DERIVATIVES AND HEDGING |
NOTE 7: DERIVATIVES AND HEDGING
The Company uses derivative instruments primarily to manage exposures to foreign currency exchange rate and to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates.
The fair values of derivative instruments and the balance sheet items to which they were recorded are summarized as follows:
The effect of derivative instruments on cash flow hedging, as well as the effect of instruments not designated as hedge and the relationship between income and other comprehensive income for the years ended December 31, 2024 and December 31, 2023, are summarized below:
(*) Classified in operating expenses in the consolidated statement of operations.
The notional amounts of the outstanding derivatives are summarized as follows:
In accordance with ASC 820, “Fair Value Measurement” (“ASC 820”) the Company measures its money market funds, marketable securities and foreign currency derivative contracts at fair value. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAIR VALUE MEASUREMENTS |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FAIR VALUE MEASUREMENTS |
NOTE 8: FAIR VALUE MEASUREMENTS
The fair value of money market funds and marketable securities was determined using quoted prices in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance.
Foreign currency derivative contracts are classified within Level 2, as the valuation inputs are based on quoted prices and market observable data of similar instruments.
The Company’s financial assets, which are measured at fair value on a recurring basis, excluding accrued interest components, consisted of the following types of instruments as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LEASES |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||
| Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||
| LEASES |
NOTE 9: LEASES
A. Operating leases
The Company has entered into various non-cancellable operating leases for its offices expiring between fiscal 2025 and 2032. Certain lease agreements contain an option for the Company to extend the lease term or an option to terminate a lease early.
The Company considers these options, which may be elected at the Company’s sole discretion, in determining the lease term on a lease-by-lease basis. Additionally, the Company entered into certain cancellable monthly lease agreements for short-term periods of up to one year.
The following is a schedule, by years, of maturities of lease liabilities as of December 31, 2024:
Refer to Note 10 for leases entered into after December 31, 2024.
Supplemental balance sheet information related to leases is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES |
12 Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||
| COMMITMENTS AND CONTINGENCIES |
NOTE 10: COMMITMENTS AND CONTINGENCIES
A. Guarantees:
As of December 31, 2024 and 2023, the Company has provided a bank guarantee in the amount of $8,264 and $6,815, respectively, to secure its lease agreement.
B. Indemnifications
The Company enters into standard indemnification provisions in the ordinary course of business, including certain customers, business partners, the Company’s officers, and directors.
Pursuant to these provisions, the Company has agreed to indemnify and defend the indemnified party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party claims because of the Company’s activities or non-compliance with certain representations and warranties made by the Company.
It is not possible to determine the maximum potential loss under these indemnification provisions due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances involved in each particular provision. To date, losses recorded in the Company’s consolidated statements of operations in connection with the indemnification provisions have not been material. There are no claims pending as of December 31, 2024 and 2023, related to indemnification agreements.
The Company has entered into service-level agreements with some of its enterprise customers defining levels of uptime reliability and performance and permitting those customers to receive credits for prepaid amounts related to unused subscription services if the Company fails to meet the defined levels of uptime in a certain calendar month. To date, the Company has not experienced any significant failures to meet defined levels of uptime reliability and performance. In addition, since the calculation is monthly for each calendar month, there is no uncertainty at the end of the reporting period. Therefore, the Company has not accrued any liabilities related to these agreements in the consolidated financial statements.
C. Legal Contingencies:
The Company is currently not involved in any material claims or legal proceedings. The Company reviews the status of each legal matter it is involved in, from time to time, in the ordinary course of business and assesses its potential financial exposure.
D. Other Commitments:
Other commitments include payments to third-party vendors for services related mainly to hosting-related services, software licenses and services.
Future minimum payments under the Company’s other commitments, as of December 31, 2024, are as follows:
Additionally, on January 27, 2025, the Company entered into an operating lease agreement for new offices in Israel. The lease shall commence on February 1, 2025. The total undiscounted cash flows amounted to $39,205 with a lease term of 10 years. This new operating lease agreement was excluded from the table above. |
FINANCIAL INCOME, NET |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Income and Expenses [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FINANCIAL INCOME, NET |
NOTE 11: FINANCIAL INCOME, NET
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RELATED PARTIES |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Related Party Transactions [Abstract] | |
| RELATED PARTIES |
NOTE 12: RELATED PARTIES
In August 2024, the Company granted 68,000 of the Company’s ordinary shares to the monday.com Foundation LTD. (“the Foundation”), an Israeli public benefit corporation (a non-for-profit organization) designated to support the Company’s social responsibility initiatives. The Foundation provides technology, education and essential skills to empower emergency response teams and youth from underserved communities, bridging the digital divide.
The shares were issued as a charitable contribution to the Foundation. The shares were fully vested on the date of grant without any performance obligations by the Foundation. The fair value of the shares totaled $17,908 at the date of grant and was recorded in general and administrative expense in the consolidated report of operations.
Additionally, the Company donated to the Foundation an amount of $6,300, which represented 1% of the gross IPO proceeds. This amount was recorded in general and administrative expense in the consolidated report of operations during 2024.
The Company’s Co-founder and the Company are both shareholders in the Foundation and each of them holds 14% of the voting rights in the Foundation. The Company does not control the Foundation, and accordingly, it does not consolidate the Foundation’s statement of activities with its financial results. Additionally, the Foundation’s shares do not have any economic rights and are not in substance to ordinary shares, therefore the Company does not apply the equity method in regards to the Foundation’s results.
In August 2024, the parties entered into a service agreement according to which the Company shall provide certain services necessary for the operation and activities of the Foundation, such as lease of office space, logistics, IT and HR. The cost of these services shall be charged and paid back to the Company by the Foundation. The fair value of these services was immaterial in 2024.
Other than as detailed above, there were no material related party transactions in each of the years ended December 31, 2024, 2023 and 2022 that were outside of the normal course of business. |
SHAREHOLDERS' EQUITY |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity Note [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SHAREHOLDERS' EQUITY |
NOTE 13: SHAREHOLDERS’ EQUITY
A. Ordinary shares:
The holders of ordinary shares are entitled to one vote per share, to dividends as decided by the Board, and in the event of the Company’s liquidation, to the surplus assets of the Company. The Company has the following ordinary shares reserved for future issuance:
B. Founder’s share:
Upon the consummation of its Initial Public Offering (“IPO”) on June 10, 2021, the Company issued one of its Co-Founders and Co-CEO one founder share.
(i) The founder share will provide the Co-CEO with certain veto rights over the approval of certain transactions, such as merger, consolidation, acquisition, issuance of equity securities or debt securities convertible into equity securities or other similar transactions, that would result in any person becoming the owner of 25% or more of the ordinary shares immediately following the consummation of such transaction, (ii) sale, assignment, conveyance, transfer, lease or other disposition, in one transaction or a series of related transactions, of all or substantially all of the Company’s assets to any person and (iii) change to the Company’s strategy, policies and/or business plan in connection with its Equal Impact Initiative.
The founder share is not tradable and has no rights other than those described above, including no dividends rights or voting rights. The founder share will automatically convert to a deferred share with no rights, upon the earlier of (i) a transfer, pledge or other disposition of the founder share, (ii) the termination of the Co-CEO’s employment with the Company, (iii) the death of the Co-CEO, (iv) the dilution of the shares and options held by him below a certain percentage.
C. Share-based compensation:
In 2024, the board of directors adopted the 2024 Foundation equity incentive plan for Foundation’s employees. The maximum aggregate number of shares that may be issued pursuant to the plan shall be up to 15,000 ordinary shares, which amount may be increased or reduced at the discretion of the board of directors.
In 2021, the board of directors adopted the 2021 equity incentive plan for employees, officers, directors, and consultants (the “2021 Plan”). Following the IPO, the Company ceased granting awards under its old plans and all shares that remained available for issuance under these plans were transferred to the 2021 Plan. The 2021 Plan provides for the grant of options to purchase ordinary shares and RSUs. Each option granted under the 2021 Plan expires no later than 10 years from the date of grant. The vesting period of the options and RSUs is generally four years. As of December 31, 2024, the number of ordinary shares reserved and available for grant and issuance pursuant to the 2021 Plan (the “Share Reserve”) was 8,941,243.
The Share Reserve will automatically increase on January 1 of each year during the term of the 2021 Plan, commencing on January 1 of the year following the year in which the 2021 Plan became effective, in an amount equal to 5% of the total number of shares of capital stock outstanding on December 31 of the preceding calendar year (hereafter: “ESOP evergreen”).
In December 2023, the board approved to reduce the ESOP evergreen for 2024 by 778,500 shares.
Since January 1, 2022, the share reserve under the 2021 Plan has been automatically increased by an aggregate of 6,300,790 shares. Awards granted under the 2021 Plan generally vest over four years. Any award that is forfeited or canceled before expiration becomes available for future grants under the 2021 Plan.
Share option activity for the year ended December 31, 2024 is as follows::
(*) Includes 73,074 performance-based options granted to the Company’s Co-CEOs in 2022, 74,108 in 2023, and 22,481 in 2024, as applicable.
The aggregate intrinsic value was calculated as the difference between the exercise price of the share options and the fair value of the underlying common shares as of December 31, 2024 and 2023. The intrinsic value of options exercised in the years ended 2024, 2023, and 2022 was approximately $265,405, $112,799 and $346,600, respectively.
The weighted-average grant-date fair value of options granted during the years ended December 31, 2024, 2023 and 2022 was $217.99, $86.26 and $69.30, respectively.
The following table summarizes the activity for the Company’s RSUs for the year ended December 31, 2024:
(*) Includes 22,928 performance-based awards granted to the Company’s Co-CEOs in 2023, and 48,129 performance-based awards to the Company’s Co-CEOs and several executives in 2024.
As of December 31, 2024, 2023 and 2022, there was $137,265, $96,112 and $64,458 of total unrecognized compensation cost related to unvested restricted share units, which is expected to be recognized over a weighted-average period of 1.77, 1.80 and 1.85 years, respectively.
Share-based compensation expense for the years ended December 31, 2024, 2023 and 2022, is as follows:
As of December 31, 2024, 2023, and 2022, unamortized share-based compensation expense was $146,335, $118,311 and $107,411, respectively, which is expected to be recognized over weighted average periods of 1.76, 1.75 and 1.79 years, respectively.
D. Employee Share Purchase Plan
Immediately prior to the IPO, the Company adopted the 2021 ESPP. As of December 31, 2021, a total of 194,625 shares were reserved for issuance under the ESPP. In addition, on the first day of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2031, the number of shares available for issuance under the ESPP will be increased by the lesser of 1% of the shares outstanding on the final day of the immediately preceding calendar year, as determined on a fully diluted basis, and such smaller number of shares as determined by the Company’s board of directors (hereafter: “ESPP evergreen”). In 2023, the board of directors approved to cancel the ESPP evergreen for 2024. According to the ESPP, eligible employees may use up to 15% of their salaries to purchase ordinary shares. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the beginning of each offering period or on the purchase date.
As of December 31, 2024, 196,467 ordinary shares had been purchased under the ESPP. The ESPP is compensatory and, as such, results in recognition of compensation cost. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INCOME TAXES |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INCOME TAXES |
NOTE 14: INCOME TAXES
E. Income (loss) before income taxes:
The following are the domestic and foreign components of the Company’s income (loss) before income taxes:
F. Income taxes:
The following are the domestic and foreign components of the Company’s income taxes:
G. Deferred taxes:
The principal components of the Company’s deferred tax assets and liabilities as of December 31, 2024 and 2023 are as follows:
In assessing the ability to realize deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. Based on the available evidence, management believes that it is more likely than not that its deferred tax assets will not be realized and accordingly, a full valuation allowance has been provided.
H. Tax rate reconciliation:
The reconciliation of the tax benefit at the Israeli statutory tax rate to the Company’s income taxes is as follows:
As of December 31, 2024, the Company has net operating loss carryforwards in Israel of 207,569, which may be carried forward indefinitely.
As of December 31, 2024, and 2023, the Company has not provided a deferred tax liability in respect of cumulative undistributed earnings relating to the Company’s foreign subsidiaries, as the Company intends to keep these earnings permanently invested.
I. Tax assessments:
As of December 31, 2024, the Company had open tax years for the periods beginning in 2020 in Israel and 2021 for the U.S. subsidiary.
J. Basis of taxation:
Ordinary taxable income in Israel is subject to a corporate tax rate of 23% in 2024 and 2023. However, the effective tax rate payable by a company may be considerably lower (as discussed below). Non-Israeli subsidiaries are taxed according to the tax laws in their respective countries of residence. Primarily, in 2024 and 2023, the Company’s U.S. subsidiary was subject to a tax rate of approximately 21%.
K. The New Technological Enterprise Incentives Regime (Amendment 73 to the Investment Law)
In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016, which includes Amendment 73 to the Law for the Encouragement of Capital Investments (“the 2017 Amendment”) was published and was pending the publication of regulations, in May 2017 regulations were promulgated by the Finance Ministry to implement the “Nexus Principles” based on OECD guidelines published as part of the Base Erosion and Profit Shifting (BEPS) project. Following the publication of the regulations, the 2017 Amendment became fully effective.
According to the 2017 Amendment, a Preferred Technological Enterprise, as defined in the 2017 Amendment, with total consolidated revenues of less than NIS 10 billion, will be subject to a 12% tax rate on income derived from intellectual property (in development area A—a tax rate of 7.5%). In order to qualify as a Preferred technological enterprise, certain criterion must be met, such as a minimum ratio of annual R&D expenditure and R&D employees, as well as having at least 25% of annual revenues derived from exports. Any dividends distributed from income from the preferred technological enterprises will be subject to tax at a rate of 20%. The 2017 Amendment further provides that, in certain circumstances, a dividend distributed to a foreign corporate shareholder, would be subject to a 4% tax rate (if the percentage of foreign investors exceeds 90%).
The Company assessed the criteria for qualifying as a “Preferred Technological Enterprise” status and concluded that the Company is eligible for the above-mentioned benefits. The Company is entitled to Preferred Technological Enterprise benefits starting in 2019. The Company did not utilize any benefits associated with the Preferred Technological Enterprise in 2024 and 2023. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EARNINGS (LOSS) PER SHARE |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EARNINGS (LOSS) PER SHARE |
NOTE 15: EARNINGS (LOSS) PER SHARE
The following table presents the calculation of basic and diluted net income (loss) per share:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEGMENT REPORTING |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SEGMENT REPORTING |
NOTE 16: SEGMENT REPORTING
ASC 280, “Segment Reporting,” establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance. The Company manages its business on the basis of one reportable segment and unit and derives revenues from service revenues (see Note 1 for a brief description of the Company’s business and Note 2n for details on the Company’s revenue recognition).
The CODM assesses the performance of the Company and decides how to allocate resources based upon consolidated net income (loss) that is also reported within the Consolidated Statements of Operations. The measure of segment assets that is reviewed by the CODM is reported within the Consolidated Balance Sheet as consolidated Total assets.
The CODM uses consolidated net income (loss) to monitor period-over-period results and decides where to allocate and invest additional resources within the business to continue growth. The following is a summary of the significant expense categories and consolidated net loss details provided to the CODM:
(*) Other segment expense items included within net income (loss) include payroll, financial income, net, advertising and marketing activities, overhead and depreciation, travel and entertainment, income taxes, information technology and communication, sales commissions and other miscellaneous expenses. See the consolidated financial statements for other financial information regarding the Company’s operating segment.
Revenues are attributed to geographic areas based on location of the end customers as follows:
Long-lived assets and operating lease right-of-use assets by geographical areas were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insider Trading Arrangements |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Cover [Abstract] | |
| Insider Trading Policies and Procedures Adopted [Flag] | true |
Cybersecurity Risk Management and Strategy Disclosure |
12 Months Ended | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||
| Cybersecurity Risk Management, Strategy, and Governance [Line Items] | ||||||||||||||||||||||
| Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] |
We have developed and implemented a cybersecurity risk management program designed to protect the confidentiality, integrity, and availability of our critical assets and information.
We design and assess our program based on the ISO 27001 and NIST frameworks, as a guide to help us identify, assess, mitigate and manage cybersecurity risks relevant to our business, impacted by industry trends and threats, regulatory updates, technological changes and strategic business direction.
Our cybersecurity risk management program is integrated into our overall enterprise risk management program and shares common methodologies, reporting channels and governance processes that apply across the enterprise risk management program to other legal, compliance, strategic, operational, and financial risk areas.
Key aspects of our cybersecurity risk management program include:
All guidelines are documented in our Risk Management Policy, which includes transparent procedures and escalation paths. We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected us, including our operations, business strategy, results of operations, or financial condition. We face certain ongoing risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition. See “Part 6 - Risk Factors – Risks Related to Privacy, Data, and Cybersecurity.” |
|||||||||||||||||||||
| Cybersecurity Risk Management Processes Integrated [Flag] | true | |||||||||||||||||||||
| Cybersecurity Risk Management Processes Integrated [Text Block] |
We have developed and implemented a cybersecurity risk management program designed to protect the confidentiality, integrity, and availability of our critical assets and information. |
|||||||||||||||||||||
| Cybersecurity Risk Management Third Party Engaged [Flag] | true | |||||||||||||||||||||
| Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] | true | |||||||||||||||||||||
| Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] | false | |||||||||||||||||||||
| Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] |
All guidelines are documented in our Risk Management Policy, which includes transparent procedures and escalation paths. We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected us, including our operations, business strategy, results of operations, or financial condition. We face certain ongoing risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition. See “Part 6 - Risk Factors – Risks Related to Privacy, Data, and Cybersecurity.” |
|||||||||||||||||||||
| Cybersecurity Risk Board of Directors Oversight [Text Block] |
Our board of directors considers cybersecurity risk as part of its risk oversight function and has delegated to its audit committee oversight of cybersecurity and other information technology risks. Our audit committee oversees management’s implementation of our cybersecurity risk management program.
Our audit committee periodically receives reports from management on our cybersecurity risks. In addition, management updates our audit committee, as necessary, regarding cybersecurity project planning, headcount, and security risk-map status and significant cybersecurity incidents.
Our audit committee reports to the full board of directors regarding its activities, including those related to cybersecurity. Our board of directors also receives briefings from management on our cybersecurity risk management program. Directors receive presentations on cybersecurity topics from our VP Chief Information Security Officer (CISO), internal security staff or external experts as part of the Committee’s continuing education on topics that impact public companies.
Our management team, led by our VP CISO with 25 years of relevant experience, is informed of and monitors the prevention, detection, mitigation, and remediation of cybersecurity risks and incidents through various means, which may include briefings from internal security personnel, threat intelligence and other information obtained from governmental, public or private sources, including external consultants engaged by us, and alerts and reports produced by security tools deployed in the information technology environment. |
|||||||||||||||||||||
| Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] |
Our board of directors considers cybersecurity risk as part of its risk oversight function and has delegated to its audit committee oversight of cybersecurity and other information technology risks. Our audit committee oversees management’s implementation of our cybersecurity risk management program. |
|||||||||||||||||||||
| Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] |
Our audit committee periodically receives reports from management on our cybersecurity risks. In addition, management updates our audit committee, as necessary, regarding cybersecurity project planning, headcount, and security risk-map status and significant cybersecurity incidents. |
|||||||||||||||||||||
| Cybersecurity Risk Role of Management [Text Block] |
Our audit committee reports to the full board of directors regarding its activities, including those related to cybersecurity. Our board of directors also receives briefings from management on our cybersecurity risk management program. Directors receive presentations on cybersecurity topics from our VP Chief Information Security Officer (CISO), internal security staff or external experts as part of the Committee’s continuing education on topics that impact public companies.
Our management team, led by our VP CISO with 25 years of relevant experience, is informed of and monitors the prevention, detection, mitigation, and remediation of cybersecurity risks and incidents through various means, which may include briefings from internal security personnel, threat intelligence and other information obtained from governmental, public or private sources, including external consultants engaged by us, and alerts and reports produced by security tools deployed in the information technology environment. |
|||||||||||||||||||||
| Cybersecurity Risk Management Expertise of Management Responsible [Text Block] | Our management team, led by our VP CISO with 25 years of relevant experience | |||||||||||||||||||||
| Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] |
Our audit committee reports to the full board of directors regarding its activities, including those related to cybersecurity. Our board of directors also receives briefings from management on our cybersecurity risk management program. Directors receive presentations on cybersecurity topics from our VP Chief Information Security Officer (CISO), internal security staff or external experts as part of the Committee’s continuing education on topics that impact public companies. |
|||||||||||||||||||||
| Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] | true |
SIGNIFICANT ACCOUNTING POLICIES (Policies) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Principles of Consolidation |
The accompanying consolidated financial statements include the accounts of monday.com and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Use of estimates |
The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
The Company bases its estimates on historical experience and on assumptions that management considers to be reasonable.
The Company assesses these estimates on a regular basis; however, actual results could differ from these estimates. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign Currency Translation and Transactions |
The Company’s management has determined that the United States dollar is the currency in the primary economic environment in which monday.com and its subsidiaries operate. Thus, the Company reports its consolidated results in United States dollars. Transactions and balances that are denominated in other currencies have been remeasured into United States dollars in accordance with principles set forth in Accounting Standards Codification (“ASC”) Topic 830, “Foreign Currency Matters” (“ASC 830”).
At the end of each reporting period, financial assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-financial assets and liabilities are remeasured at historical exchange rates. Gains and losses related to remeasurement are recorded as financial income, net in the consolidated statements of operations as appropriate. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents |
The Company classifies all unrestricted highly liquid investments with maturities of three months or less at the date of purchase as cash equivalents. Cash equivalents consist of bank deposits and money market funds. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment in marketable securities |
The Company accounts for investments in marketable securities in accordance with ASC Topic 320, “Investments - Debt Securities” (“ASC 320”). Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determinations at each balance sheet date. The Company classifies all of its debt securities as available-for-sale (“AFS”) as the Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its marketable securities within current assets on the consolidated balance sheet.
Available-for-sale debt securities are carried at fair value, with the unrealized gains and losses, net of tax, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses on sale of investments are included in financial income, net and are derived using the specific identification method for determining the cost of securities sold.
The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity.
Such amortization together with accretion of interest on securities is included in financial income, net. At each reporting period, the Company evaluates whether declines in fair value below amortized cost are due to expected credit losses, as well as the company’s ability and intent to hold the investment until a forecasted recovery occurs in accordance with ASC Topic 326, “Financial Instrument- Credit losses” (“ASC 326”). Allowance for credit losses on AFS debt securities is recognized in the Company’s consolidated statements of operations, and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in shareholders’ equity. No credit losses were recognized during the year ended December 31, 2024. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounts Receivable |
Accounts receivable are recorded at the invoiced amount, are unsecured and do not bear interest. The Company maintains an allowance for credit losses inherent in its accounts receivable including potential uncollectible amounts.
The allowance is based on the Company’s periodic assessment of the collectability of the accounts based on a combination of factors including the payment terms of each account, its age, the collection history of each customer, and the customer’s financial condition.
Expenses associated with credit losses for the years ended December 31, 2024, 2023 and 2022 were $2,525, $2,040 and $1,622, respectively. The Company wrote off bad debts in the amount of $2,547, $2,130 and $1,463 during 2024, 2023 and 2022, respectively. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment in affiliated company |
The Company accounts for an equity method investment over which it has significant influence but does not own a majority of the equity interests or otherwise controls and the investment is either in common stock or in substance common stock using the equity method, in accordance with ASC Topic 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”). The Company’s share of the investee’s profit and loss is recognized in the consolidated statements of operations.
Management’s judgment regarding the level of influence over its equity method investee includes considering key factors such as the Company’s ownership interest, representation on the board of directors, participation in policy-making decisions and material intercompany transactions.
The Company assesses its equity method investment for other-than-temporary impairment by considering factors as well as all relevant and available information including, but not limited to, current economic and market conditions, the operating performance of the affiliated company, including current earnings trends, and other affiliated company-specific information such as financing rounds. During 2024, no impairment loss was recognized in the Company’s consolidated statement of operations.
The net carrying value of the investment in the affiliated company amounted to $6,000 as of December 31, 2024 and is presented as part of other-long term assets in the consolidated balance sheet. There were no investments in affiliated companies in 2023. Equity gains (losses) were immaterial in 2024. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Property and Equipment, Net |
Property and equipment, net is stated at cost, less accumulated depreciation and amortization. Depreciation is computed on a straight-line basis over the estimated useful lives of the related assets (see Note 2j). Expenditures for maintenance and repairs are expensed as incurred. Disposals are removed at cost less accumulated depreciation and any gain or loss from disposals is reflected in the consolidated statement of operations in the period of disposition. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Internal Use Software Development Costs |
The Company capitalizes certain internal use software development costs related to its cloud-based platform (amortized over 3 years) or to back-office operating systems (amortized over six years). The costs consist of personnel costs incurred during the application development stage. Capitalization begins when the preliminary project stage is completed, and it is probable that the software will be completed and used for its intended function.
Capitalization ceases when the software is substantially complete and ready for its intended use, including the completion of all significant testing. Costs related to preliminary project activities and post implementation operating activities are expensed as incurred.
Capitalized software development costs are included in property and equipment, net in the consolidated balance sheet (see Note 5) and are amortized over the estimated useful life of the software, on a straight-line basis, which represents the manner in which the expected benefit will be derived. Amortization expenses are included in cost of revenue in the consolidated statement of operations. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Depreciation, Amortization and Impairment of Long-Lived Assets |
Long-lived assets with definite lives consist of property and equipment. Long-lived assets are amortized over their estimated useful lives which are as follows:
The Company reviews its long-lived assets for impairment whenever events or circumstances have occurred that indicate that the estimated useful lives of the long-lived assets may warrant revision or that the carrying value of these assets may be impaired. To compute whether assets have been impaired, the estimated undiscounted future cash flows of the assets or asset group are compared to the carrying value. If the undiscounted future cash flows are less than the carrying value, an impairment loss is recognized based on the amount in which the carrying amount exceeds the fair value of the asset or asset group, based on discounted cash flows. There were no events or circumstances that required the Company’s long-lived assets to be tested for impairment during any of the periods presented. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases |
The Company accounts for its leases in accordance with ASC Topic 842, “Leases” (“ASC 842”). The Company determines if an arrangement is a lease at inception by determining if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration and other facts and circumstances.
The Company classifies leases at their inception as either capital or operating leases. A lease that transfers substantially all the risks and rewards incidental to ownership of the leased asset to the Company is classified as a capital lease. For capital leases, at the commencement of the lease term, the leased asset is measured at the lower of fair value or the present value of the minimum lease payments. The leased asset is depreciated over the shorter of its useful life and the lease term.
For operating leases, right-of-use (“ROU”) assets and lease liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. As the Company’s leases do not provide an implicit rate, the Company uses the incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company’s understanding of what its credit rating would be. The ROU assets also include any lease payments made prior to commencement and are recorded net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The lease agreements may contain variable costs such as common area maintenance, insurance, real estate taxes or other costs. Variable lease costs are expensed as incurred on the consolidated statements of operations and are not included in the operating lease ROU assets and lease liabilities. Certain lease agreements include rental payments adjusted periodically for the consumer price index (“CPI”). The ROU assets and lease liabilities were calculated using the initial CPI and will not be subsequently adjusted.
The Company’s lease agreements generally do not contain any residual value guarantees, restrictions, or covenants.
For operating leases that contain renewals, or other lease incentives, the Company recognizes the rent expense on a straight-line basis over the term of the lease. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.
The Company utilized the practical expedient in ASC 842 and elected not to record leases with an initial term of 12 months or less on the balance sheet. Therefore, for short-term leases with a term of 12 months or less, operating lease ROU assets and lease liabilities are not recognized, and the Company records such lease payments in the consolidated statements of operations on a straight-line basis over the lease term.
Rent expenses for the years ended December 31, 2024, 2023 and 2022, were $27,038, $21,369, and $16,396, respectively. See also Note 9. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Employee Related Obligations |
According to the Israeli Severance Pay Law, 1963 (“Severance Pay Law”), employees are entitled to severance payment, following the termination of their employment. Under the Severance Pay Law, the severance payment is calculated as one-month salary for each year of employment, or a portion thereof. The Company’s liability for severance pay is covered by the provisions of Section 14 of the Severance Pay Law (“Section 14”).
Under Section 14 employees are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, contributed on their behalf to their insurance funds. Payments in accordance with Section 14 release the Company from any future severance payments in respect of those employees. Therefore, the Company does not recognize a liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset in the Company’s consolidated balance sheet. Severance expenses for the years ended December 31, 2024, 2023 and 2022, amounted to $11,086, $8,435 and $7,289, respectively.
The Company’s U.S. Subsidiary has a 401(K) defined contribution plan covering certain employees in the U.S. All eligible employees may elect to contribute up to 100% of their annual compensation to the plan through salary deferrals, subject to Internal Revenue Service limits. The expenses recorded by the U.S. subsidiary for employer’s contributions were $2,493, $1,898 and $1,551 for the years ended December 31, 2024, 2023 and 2022, respectively. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Contingent Liabilities |
The Company accounts for its contingent liabilities in accordance with ASC Topic 450, “Contingencies” (“ASC 450”). A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.
With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revenue Recognition |
The Company generates revenue from the sale of subscriptions to customers to access its cloud-based Work OS platform. The terms of the Company’s subscription agreements are primarily monthly or annual, and a large portion of the arrangements are paid in full up-front at the outset of the arrangement. Customers may not take possession over the software and instead are granted continuous access to the platform over the contractual period and therefore the arrangements are accounted for as service contracts.
The Company’s contracts generally include fixed number of users and fixed price per user. Revenue for these arrangements is recognized ratably over the contract term.
The Company’s subscription contracts are generally non-cancelable except for contracts with first-time customers whereby the contract terms provide rights to cancel the contract in the first 30 days for pro-rated refund for unutilized days. Historically, refunds have not been material, and therefore no provision for refunds was recorded to date.
In accordance with ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”), revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration the Company expects to be entitled to receive in exchange for these services.
The Company determines revenue recognition through the following steps:
The Company considers the terms and conditions of the contracts and the Company’s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party’s rights regarding the services to be transferred and the payment terms for the services, it has determined the customer to have the ability and intent to pay, and the contract has commercial substance.
The Company applies certain judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s payment history or, in the case of a new customer, credit and financial information pertaining to the customer.
Performance obligations committed in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services and the products is separately identifiable from other promises in the contract.
The Company’s performance obligations generally consist of access to the cloud-based platform and related support services which is considered one performance obligation.
The customers do not have the ability to take possession of the software, and through access to the platform the Company provides a series of distinct software-based services that are satisfied over the term of the subscription.
The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring services to the customer.
Payment terms are generally upfront at the time of the transaction, except for enterprise customers which are generally net 30 days. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts generally do not include a significant financing component. The Company applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component.
The Company’s policy is to exclude sales and other indirect taxes when measuring the transaction price.
The Company’s contracts contain a single performance obligation. Therefore, the entire transaction price is allocated to the single performance obligation.
Revenue is recognized ratably over the term of the subscription agreement generally beginning on the date that the platform is made available to a customer.
Contract balances
Contract assets consist of unbilled accounts receivable, which occur when a right to consideration for the Company’s performance under the customer contract occurs before invoicing to the customer. The amount of unbilled accounts receivable included within accounts receivable, net on the consolidated balance sheets was immaterial for the periods presented.
Contract liabilities consist of deferred revenues. The Company records contract liabilities when cash payments are received in advance of performance to deferred revenue or to customer advances in case of refund rights.
The Company recognized $266,284, $198,099 and $134,438 of revenue during the years ended December 31, 2024, 2023 and 2022, respectively, that were included in the deferred revenue balance at the beginning of the respective year.
Remaining performance obligations
The Company has elected to apply the practical expedient in ASC 606 and does not disclose the value of unsatisfied performance obligations for unearned revenue since the original expected duration of the majority of the contracts is one year or less.
Contract costs
The Company accounts for costs to obtain revenue contracts in accordance with ASC Topic 340-40, “Other assets and deferred costs” (“ASC 340-40”). Sales commissions earned by external partners and by internal salespersons are considered incremental and recoverable costs of acquiring customer contracts. These costs are capitalized and amortized on a straight-line basis over the anticipated period of benefit, which is estimated to be three years, taking into consideration anticipated contract renewals. The Company determined the period of benefit by taking into consideration historical customer attrition rates, the useful life of the Company’s technology, and other factors.
Deferred contract costs amounted to $20,522 and $3,675 as of December 31, 2024 and 2023, respectively. Amounts expected to be recognized in excess of one year as of the balance sheet date are recorded as other long-term assets, in the consolidated balance sheets.
Deferred contract costs are periodically analyzed for impairment. There were no impairment losses recorded during the periods presented. Amortization is recorded within sales and marketing expense in the consolidated statements of operations. Amortization expenses related to deferred contract costs amounted to $6,382 in 2024, and $0 in each of 2023 and 2022.
The Company has elected to apply the practical expedient allowed by ASC 606 according to which incremental costs of obtaining a contract are recognized as an expense when incurred if the amortization period of the asset is one year or less, and the initial commission rate is commensurate with the commission rate on subsequent renewals. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
Cost of revenue primarily consists of costs related to providing subscription services to paying customers, including hosting costs, personnel-related expenses of customer support including share-based compensation, subcontractors costs, merchant and credit-cards processing fees, amortization of capitalized software development costs and allocated overhead costs. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Research and Development Costs |
Research and development costs are expensed as incurred unless these costs qualify for capitalization as internal-use software development costs.
Research and development expenses consist primarily of personnel-related expenses, including share-based compensation and allocated overhead costs. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sales and Marketing |
Sales and marketing expenses are primarily comprised of costs of the Company’s marketing personnel including share-based compensation, online marketing expenses and other advertising costs, partners’ commissions and allocated overhead costs. Sales and marketing expenses are expensed as incurred. Advertising costs amounted to $218,415, $203,235 and $181,447, in the years ended December 31, 2024, 2023 and 2022, respectively. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| General and Administrative |
General and administrative expenses primarily consist of personnel-related and share-based compensation expenses associated with the Company’s executives, as well as its finance, legal, human resources and other operational and administrative functions, professional fees for external legal, accounting, and other consulting services, directors and officer’s insurance expenses, donations, charitable contributions to the Monday.com Foundation and allocated overhead costs. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting for Share-Based Compensation |
The Company accounts for share-based compensation under ASC Topic 718, Compensation - Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to employees, non-employee consultants and directors, including options, restricted share units (“RSUs”), and shares issued pursuant to the 2021 Employee Share Purchase Plan (“ESPP”) based on the fair value of the awards on the date of grant as follows:
(i) share options – the fair value is based on the Black-Scholes option-pricing model, (ii) RSUs – the fair value is based on the closing trading price of the underlying shares at the date of grant and, (iii) ESPP – the fair value is based on the Monte-Carlo simulation model due to certain limitation on the number of shares per employee.
The expense for share-based compensation cost is recognized over the requisite service period of each individual grant using the graded vesting attribution method for both service-based and performance-based awards. Forfeitures are accounted for as they occur.
The Company granted performance-based awards to its Co-Chief Executive Officers (“Co-CEOs”) and several other members of its senior management. The number of performance-based awards earned and eligible to vest are generally determined after a one-year performance period, based on achievement of certain Company financial performance measures and the recipient’s continued service.
The Company recognizes share-based compensation expense for the performance-based awards using the fair value at the date of grant over the requisite service when it is probable that the performance conditions will be achieved.
The Company adjusts the number of units expected to vest based on estimates of performance against the pre-set objectives.
Valuation assumptions used in measuring compensation costs:
The Black-Scholes option-pricing model requires the Company to make several assumptions, including the value of the Company’s ordinary shares, expected volatility, expected term, risk-free interest rate and expected dividends. The Company evaluates the assumptions used to value option awards upon each grant of share options.
Expected volatility was calculated based on the implied volatilities from market comparisons of certain publicly traded companies. The expected option term was calculated based on the simplified method, which uses the midpoint between the vesting date and the contractual term, as the Company does not have sufficient historical data to develop an estimate based on participant behavior. The risk-free interest rate was based on the U.S. treasury bonds yield with an equivalent term. The Company has not paid dividends and has no foreseeable plans to pay dividends.
The assumptions used to determine the fair value of the share-based awards are management’s best estimates and involve inherent uncertainties and the application of judgment.
The following table summarizes the Black-Scholes assumptions used at the grant dates:
The following table summarizes the Monte-Carlo model assumptions used at the grant dates:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Taxes |
The Company accounts for income taxes in accordance with ASC Topic 740, “Income Taxes” (“ASC 740”), using the liability method whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized. As of December 31, 2024 and 2023, the Company recorded a full valuation allowance against its deferred tax assets.
The Company applies a more-likely-than-not recognition threshold to uncertain tax positions based on the technical merits of the income tax positions taken.
The Company does not recognize a tax benefit unless it is more likely than not that the tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit that is recorded for these positions is measured at the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. As of December 31, 2024 and 2023, no liability for unrecognized tax benefits was recorded due to immateriality. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Income (Loss) Per Share |
The Company’s basic net income (loss) per share is calculated by dividing net income (loss) attributable to ordinary shareholders by the weighted-average number of shares of ordinary shares outstanding for the period, without consideration of potentially dilutive securities.
The diluted net income (loss) per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury shares method or the if-converted method based on the nature of such securities.
In periods in which the Company had a net loss, diluted net loss per share was the same as basic net loss per share since the effects of potentially dilutive shares of ordinary shares were anti-dilutive.
The total weighted average number of shares related to the outstanding options and RSUs that were excluded from the calculations of diluted earnings per share, since it would have an anti-dilutive effect, were 135,191 shares, 4,294,853 shares and 4,617,018 shares for 2024, 2023 and 2022, respectively.
The Founder’s share is not a participating security and therefore excluded from the net income (loss) per share. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Concentration of Credit Risks |
Financial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents (including money market funds and bank deposits up to three months), marketable securities and accounts receivable.
For cash and cash equivalents, the Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits. The Company places its cash and cash equivalents with financial institutions with high-quality credit ratings in the United States, Israel, Ireland, Cayman Islands, and Luxembourg and has not experienced any losses in such accounts.
The Company’s marketable securities consist of investments in U.S. government treasury bills. The Company’s investment policy limits the amount that the Company may invest in any one type of investment or issuer, thereby reducing credit risk concentrations.
For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying consolidated balance sheets. For each of the years ended December 31, 2024, and 2023, there were no individual customers that accounted for 10% or more of the Company’s revenues. The Company’s accounts receivable are geographically diversified and derived primarily from sales in the United States, EMEA, and APAC. To manage its accounts receivable risk, the Company evaluates the credit worthiness of its customers and maintains allowances for potential credit losses.
The Company has not historically experienced any material credit losses related to individual customers or groups of customers in any specific area or industry. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Information |
W. Segment Information
The Company has a single operating and reportable segment. The Company’s chief operating decision makers are its two Co-Chief Executive Officers (“Co-CEOs”), who review financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources.
For information regarding the Company’s long-lived assets and revenue by geographic area, as well as a summary of significant expense categories, see Note 16. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value measurements |
X. Fair Value measurements
Fair value is defined as the exchange price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company measures financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Three levels of inputs may be used to measure fair value:
The carrying amount of cash and cash equivalents, accounts receivable, prepaid expenses, accounts payable, and accrued expenses, are stated at their carrying value, which approximates fair value due to the short maturities of these instruments.
Assets measured at fair value on a recurring basis as of December 31, 2024 and 2023, are comprised of money market funds, marketable securities, and derivative instruments (see Note 8). |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Financial Instruments |
Y. Derivative Financial Instruments
Derivatives are recognized at fair value as either assets or liabilities in the consolidated balance sheets in accordance with ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The gain or loss of derivatives which are designated and qualify as hedging instruments in a cash flow hedge, is recorded under accumulated other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Derivatives are classified within Level 2 of the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments.
The Company’s primary objective for holding derivative instruments is to reduce its exposure to foreign currency rate changes. The Company reduces its exposure by entering into forward foreign exchange contracts and option contracts with respect to operating expenses that are forecasted to be incurred in currencies other than the U.S. dollar.
A majority of the Company’s revenues and operating expenditures are transacted in U.S. dollars. However, certain operating expenditures are incurred in or exposed to other currencies, primarily the New Israeli Shekel (“NIS”).
The Company has established forecasted transaction currency risk management programs to protect against fluctuations in fair value and the volatility of future cash flows caused by changes in exchange rates. The Company’s currency risk management program includes foreign exchange contracts designated as cash flow hedges. These foreign exchange contracts generally mature within 12 months (see Note 7).
In addition, occasionally the Company enters into swaps, options and forward contracts to hedge a portion of its monetary items in the balance sheet, such as cash and cash equivalents balances, denominated in other currencies for short-term periods. The purpose of these contracts is to protect the fair value of the monetary assets from foreign exchange rate fluctuations. Gains and losses from derivatives related to these contracts are not designated as hedging instruments. The Company does not enter into derivative financial instruments for trading or speculative purposes. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recently Adopted Accounting Pronouncements |
Z. Recently Adopted Accounting Pronouncements:
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures” (“ASU 2023-07”) to improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses on an interim and annual basis. All disclosure requirements of ASU 2023-07 are also required for entities with a single reportable segment. ASU 2023-07 is effective starting January 1, 2024 and should be applied on a retrospective basis to all periods presented. The adoption of this ASU did not have a material impact on the Company’s financial statements (see also Note 16). |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Pronouncements Not Yet Effective |
AA. Accounting pronouncements not yet effective
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740) – Improvements to Income Tax Disclosures” (“ASU 2023-09”). The ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as provide additional information for reconciling items that meet a quantitative threshold. Further, the ASU requires certain disclosures of state versus federal income tax expense and taxes paid. The amendments in this ASU are required to be adopted starting January 1, 2025. Early adoption is permitted, and the amendments should be applied on a prospective basis. The Company is currently evaluating the effect of adopting the ASU on its related disclosures.
In November 2024, the FASB issued ASU 2024-03, “Income Statement–Reporting Comprehensive Income–Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), which requires the disaggregation of certain expenses in the financial statements notes, to provide enhanced transparency into the expense captions presented on the face of the consolidated statement of operations. ASU 2024-03 is effective for annual reporting periods beginning January 1, 2027 and interim periods beginning January 1, 2028 and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact that ASU 2024-03 will have on its related disclosures, and the transition method. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SIGNIFICANT ACCOUNTING POLICIES (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||
| Schedule of useful lives of long-lived assets |
|
||||||||||||||||||||||||||||||||||||||||||
| Schedule of black-scholes stock option assumptions used at the grant dates |
|
||||||||||||||||||||||||||||||||||||||||||
| Schedule of black-scholes ESPP assumptions used at the grant dates |
|
||||||||||||||||||||||||||||||||||||||||||
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of cash and cash equivalents and marketable securities |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of available-for-sale marketable securities |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid Expense and Other Assets, Current [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of prepaid expenses and other current assets |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
PROPERTY AND EQUIPMENT, NET (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Property, Plant and Equipment [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of property and equipment, net |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||
| Accrued Liabilities, Current [Abstract] | ||||||||||||||||||||||||||||||||||||
| Schedule of accrued expenses and other current liabilities |
|
|||||||||||||||||||||||||||||||||||
DERIVATIVES AND HEDGING (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of fair values of derivative instruments |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of income and other comprehensive income |
(*) Classified in operating expenses in the consolidated statement of operations. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of notional amounts of outstanding derivative |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAIR VALUE MEASUREMENTS (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of fair value of financial assets and liabilities |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LEASES (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||
| Leases [Abstract] | |||||||||||||||||||||||||||||||
| Schedule of operating leases future minimum lease payments |
|
||||||||||||||||||||||||||||||
| Schedule of supplemental balance sheet information |
|
||||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENCIES (Tables) |
12 Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||
| Schedule of future minimum payments, other commitments, liability, fiscal year maturity |
|
FINANCIAL INCOME, NET (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Income and Expenses [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of financial income (expenses) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHAREHOLDERS' EQUITY (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of ordinary shares reserved for future issuance |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of share option activity |
(*) Includes 73,074 performance-based options granted to the Company’s Co-CEOs in 2022, 74,108 in 2023, and 22,481 in 2024, as applicable. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of unvested restricted stock units |
(*) Includes 22,928 performance-based awards granted to the Company’s Co-CEOs in 2023, and 48,129 performance-based awards to the Company’s Co-CEOs and several executives in 2024. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of share-based compensation expense |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INCOME TAXES (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of domestic and foreign components of loss before income taxes |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of domestic and foreign components of income taxes |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of deferred tax assets and liabilities |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of effective tax rate reconciliation |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EARNINGS (LOSS) PER SHARE (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of calculation of basic and diluted net income (loss) per share |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEGMENT REPORTING (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of the significant expense categories and consolidated net loss details provided to the CODM |
(*) Other segment expense items included within net income (loss) include payroll, financial income, net, advertising and marketing activities, overhead and depreciation, travel and entertainment, income taxes, information technology and communication, sales commissions and other miscellaneous expenses. See the consolidated financial statements for other financial information regarding the Company’s operating segment. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of revenues attributed to geographic areas based on location of end customers |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of property and equipment, net by geographical areas |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
| Doubtful accounts expense | $ 2,525 | $ 2,040 | $ 1,622 |
| Bad debts written off | 2,547 | 2,130 | 1,463 |
| Rent expenses | 27,038 | 21,369 | 16,396 |
| Deferred costs | 20,522 | 3,675 | |
| Amortization expenses related to deferred contract costs | 6,382 | 0 | 0 |
| Severance Costs | 11,086 | 8,435 | 7,289 |
| Maximum annual contributions | 2,493 | 1,898 | 1,551 |
| Deferred revenue, revenue recognized | 266,284 | 198,099 | 134,438 |
| Advertising Expense | $ 218,415 | $ 203,235 | $ 181,447 |
| Outstanding share options and RSUs | |||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
| Antidilutive securities excluded from computation of earnings per share | 135,191 | 4,294,853 | 4,617,018 |
SIGNIFICANT ACCOUNTING POLICIES (Details) |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Computers, software, and electronic equipment | Minimum | |
| Property, Plant and Equipment [Line Items] | |
| Useful life | 3 years |
| Computers, software, and electronic equipment | Maximum | |
| Property, Plant and Equipment [Line Items] | |
| Useful life | 5 years |
| Office furniture and equipment | Minimum | |
| Property, Plant and Equipment [Line Items] | |
| Useful life | 10 years |
| Office furniture and equipment | Maximum | |
| Property, Plant and Equipment [Line Items] | |
| Useful life | 14 years |
| internal use software development costs | Minimum | |
| Property, Plant and Equipment [Line Items] | |
| Useful life | 3 years |
| internal use software development costs | Maximum | |
| Property, Plant and Equipment [Line Items] | |
| Useful life | 6 years |
| Leasehold improvements | |
| Property, Plant and Equipment [Line Items] | |
| Estimated useful lives | Shorter of the remaining termof the underlying lease, orestimated useful life of the asset |
SIGNIFICANT ACCOUNTING POLICIES (Details 1) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Expected dividend yield | 0.00% | 0.00% | 0.00% |
| Expected volatility | 58.00% | ||
| Minimum | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Risk-free interest rate | 4.03% | 3.48% | 1.89% |
| Expected term (in years) | 5 years | 5 years | 5 years |
| Expected volatility | 57.00% | 49.00% | |
| Maximum | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Risk-free interest rate | 4.77% | 4.49% | 4.30% |
| Expected term (in years) | 7 years | 7 years | 7 years |
| Expected volatility | 65.00% | 57.00% | |
SIGNIFICANT ACCOUNTING POLICIES (Details 2) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Expected dividend yield | 0.00% | 0.00% | 0.00% |
| Expected volatility | 58.00% | ||
| Employee stock purchase plan [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Expected dividend yield | 0.00% | 0.00% | 0.00% |
| Expected term (in years) | 6 months | 6 months | 6 months |
| Minimum | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Risk-free interest rate | 4.03% | 3.48% | 1.89% |
| Expected term (in years) | 5 years | 5 years | 5 years |
| Expected volatility | 57.00% | 49.00% | |
| Minimum | Employee stock purchase plan [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Risk-free interest rate | 4.34% | 4.92% | 0.46% |
| Expected volatility | 48.00% | 54.00% | 97.00% |
| Maximum | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Risk-free interest rate | 4.77% | 4.49% | 4.30% |
| Expected term (in years) | 7 years | 7 years | 7 years |
| Expected volatility | 65.00% | 57.00% | |
| Maximum | Employee stock purchase plan [Member] | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Risk-free interest rate | 5.12% | 5.24% | 2.87% |
| Expected volatility | 50.00% | 80.00% | 98.00% |
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES (Narrative) (Details) $ in Thousands |
Dec. 31, 2024
USD ($)
|
|---|---|
| Marketable Securities [Member] | |
| Marketable Securities [Line Items] | |
| Interest receivable on marketable securities | $ 86 |
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Cash and Cash Equivalents, at Carrying Value [Abstract] | ||
| Cash | $ 98,392 | $ 91,470 |
| Due from Banks | 21,936 | 0 |
| Money Market Funds, at Carrying Value | 1,291,274 | 1,024,658 |
| Total cash and cash equivalents | 1,411,602 | 1,116,128 |
| Marketable Securities [Abstract] | ||
| Total marketable securities | 50,004 | 0 |
| Total cash and cash equivalents and marketable securities | 1,461,606 | 1,116,128 |
| U.S. Treasury bills [Member] | ||
| Marketable Securities [Abstract] | ||
| Total marketable securities | $ 50,004 | $ 0 |
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES (Details 1) $ in Thousands |
Dec. 31, 2024
USD ($)
|
|---|---|
| Amortized cost | |
| Within one year | $ 49,797 |
| After one year through five years | 0 |
| Total | 49,797 |
| Gross unrealized gains | |
| Within one year | 207 |
| After one year through five years | 0 |
| Total | 207 |
| Gross unrealized losses | |
| Within one year | 0 |
| After one year through five years | 0 |
| Total | 0 |
| Fair value | |
| Within one year | 50,004 |
| After one year through five years | 0 |
| Total | $ 50,004 |
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Prepaid Expense and Other Assets, Current [Abstract] | ||
| Prepaid expenses | $ 15,944 | $ 13,189 |
| Related parties’ receivable | 1,587 | 6,337 |
| Government institutions | 7,376 | 2,731 |
| Derivative instruments | 2,984 | 9,806 |
| Interest receivable | 4,864 | 4,484 |
| Short-term vendor deposits | 335 | 338 |
| Deferred contract costs | 10,409 | 1,810 |
| Other current assets | 1,337 | 408 |
| Total prepaid expenses and other current assets | $ 44,836 | $ 39,103 |
PROPERTY AND EQUIPMENT, NET (Narrative) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Property, Plant and Equipment [Abstract] | |||
| Depreciation and amortization expense | $ 11,858 | $ 8,961 | $ 5,913 |
| Capital losses | 576 | 62 | 0 |
| Capitalized costs related to the development of internal-use software | 3,013 | 4,019 | 4,931 |
| Amortization of capitalized software development costs | 3,883 | 2,558 | $ 1,492 |
| Net carrying value of capitalized internal-use software | $ 8,823 | $ 9,693 | |
PROPERTY AND EQUIPMENT, NET (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Property, Plant and Equipment [Line Items] | ||
| Property and equipment, gross | $ 70,599 | $ 55,378 |
| Less accumulated depreciation and amortization | (29,023) | (17,960) |
| Property and equipment, net | 41,576 | 37,418 |
| Computer, software, and electronic equipment | ||
| Property, Plant and Equipment [Line Items] | ||
| Property and equipment, gross | 20,912 | 14,995 |
| Office furniture and equipment | ||
| Property, Plant and Equipment [Line Items] | ||
| Property and equipment, gross | 9,804 | 9,094 |
| Leasehold improvements | ||
| Property, Plant and Equipment [Line Items] | ||
| Property and equipment, gross | 22,000 | 16,419 |
| Capitalized internal use software development costs | ||
| Property, Plant and Equipment [Line Items] | ||
| Property and equipment, gross | 17,629 | 14,616 |
| Capital leases | ||
| Property, Plant and Equipment [Line Items] | ||
| Property and equipment, gross | $ 254 | $ 254 |
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Accrued Liabilities, Current [Abstract] | ||
| Accrued employee compensation and benefits | $ 95,960 | $ 63,440 |
| Accrued expenses | 56,528 | 31,810 |
| Advances from customers | 3,431 | 2,801 |
| Income and indirect taxes payable | 15,121 | 8,640 |
| Total | $ 171,040 | $ 106,691 |
DERIVATIVES AND HEDGING (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Derivative [Line Items] | ||
| Derivative instruments | $ 2,984 | $ 9,806 |
| Designated as Hedging Instrument [Member] | ||
| Derivative [Line Items] | ||
| Derivative instruments | 2,984 | 9,806 |
| Not Designated as Hedging Instrument [Member] | ||
| Derivative [Line Items] | ||
| Derivative instruments | 0 | 0 |
| Foreign exchange contracts | Prepaid expenses and other current assets | Designated as Hedging Instrument [Member] | ||
| Derivative [Line Items] | ||
| Derivative instruments | $ 2,984 | $ 9,806 |
| Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] | Other Assets, Current |
DERIVATIVES AND HEDGING (Details 1) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Derivative [Line Items] | |||
| Gain (Loss) Recognized in Other Comprehensive Income on Effective-Portion of Derivative, net | $ (961) | $ 4,273 | $ (11,386) |
| Realized Loss (gains) on Derivative Reclassified from Accumulated Other Comprehensive Income | (5,861) | 8,741 | $ 7,582 |
| Designated as hedging Instrument | |||
| Derivative [Line Items] | |||
| Gain (Loss) Recognized in Other Comprehensive Income on Effective-Portion of Derivative, net | (961) | 4,273 | |
| Realized Loss (gains) on Derivative Reclassified from Accumulated Other Comprehensive Income | (5,861) | 8,741 | |
| Amount Excluded from Effectiveness Testing Recognized in Income (Loss) | 0 | 0 | |
| Not designated as hedging instrument | |||
| Derivative [Line Items] | |||
| Gain (Loss) Recognized in Other Comprehensive Income on Effective-Portion of Derivative, net | 0 | 0 | |
| Realized Loss (gains) on Derivative Reclassified from Accumulated Other Comprehensive Income | 0 | 0 | |
| Amount Excluded from Effectiveness Testing Recognized in Income (Loss) | 0 | 0 | |
| Foreign exchange contracts | Designated as hedging Instrument | |||
| Derivative [Line Items] | |||
| Gain (Loss) Recognized in Other Comprehensive Income on Effective-Portion of Derivative, net | (961) | 4,273 | |
| Realized Loss (gains) on Derivative Reclassified from Accumulated Other Comprehensive Income | (5,861) | 8,741 | |
| Amount Excluded from Effectiveness Testing Recognized in Income (Loss) | 0 | 0 | |
| Foreign exchange contracts | Not designated as hedging instrument | |||
| Derivative [Line Items] | |||
| Gain (Loss) Recognized in Other Comprehensive Income on Effective-Portion of Derivative, net | 0 | 0 | |
| Realized Loss (gains) on Derivative Reclassified from Accumulated Other Comprehensive Income | 0 | 0 | |
| Amount Excluded from Effectiveness Testing Recognized in Income (Loss) | $ 0 | $ 0 | |
DERIVATIVES AND HEDGING (Details 2) ₪ in Thousands, $ in Thousands |
Dec. 31, 2024
ILS (₪)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
ILS (₪)
|
Dec. 31, 2023
USD ($)
|
|---|---|---|---|---|
| Foreign exchange contracts | ||||
| Derivative [Line Items] | ||||
| Derivatives designated as hedging instruments | ₪ 209,487 | $ 209,487 | ₪ 157,430 | $ 157,430 |
FAIR VALUE MEASUREMENTS (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Total | $ 1,344,262 | $ 1,034,464 |
| U.S. Treasury bills [Member] | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Marketable securities | 50,004 | 0 |
| Money Market Funds [Member] | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Cash equivalents | 1,291,274 | 1,024,658 |
| Foreign exchange contracts | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Foreign currency derivative contracts | 2,984 | 9,806 |
| Level 1 [Member] | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Total | 1,341,278 | 1,024,658 |
| Level 1 [Member] | U.S. Treasury bills [Member] | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Marketable securities | 50,004 | 0 |
| Level 1 [Member] | Money Market Funds [Member] | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Cash equivalents | 1,291,274 | 1,024,658 |
| Level 1 [Member] | Foreign exchange contracts | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Foreign currency derivative contracts | 0 | 0 |
| Level 2 [Member] | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Total | 2,984 | 9,806 |
| Level 2 [Member] | U.S. Treasury bills [Member] | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Marketable securities | 0 | 0 |
| Level 2 [Member] | Money Market Funds [Member] | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Cash equivalents | 0 | 0 |
| Level 2 [Member] | Foreign exchange contracts | ||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
| Foreign currency derivative contracts | $ 2,984 | $ 9,806 |
LEASES (Details) $ in Thousands |
Dec. 31, 2024
USD ($)
|
|---|---|
| Leases [Abstract] | |
| 2025 | $ 29,851 |
| 2026 | 22,916 |
| 2027 | 18,872 |
| 2028 | 16,577 |
| 2029 | 9,144 |
| Thereafter | 23,209 |
| Total undiscounted cash flows | 120,569 |
| Less: Imputed interest | (14,533) |
| Present value of lease liabilities | $ 106,036 |
LEASES (Details 1) |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Leases [Abstract] | ||
| Weighted-average remaining lease term | 5 years 2 months 12 days | 3 years 8 months 12 days |
| Weighted-average discount rate | 4.20% | 3.50% |
COMMITMENTS AND CONTINGENCIES (Narrative) (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Commitments and Contingencies Disclosure [Abstract] | ||
| Bank guarantee to secure lease agreements | $ 8,264 | $ 6,815 |
| Total undiscounted cash flows | $ 39,205 | |
| Lease term | 10 years | |
COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands |
Dec. 31, 2024
USD ($)
|
|---|---|
| Commitments and Contingencies Disclosure [Abstract] | |
| 2025 | $ 58,825 |
| 2026 | 36,541 |
| 2027 | 17,942 |
| Total contractual obligations | $ 113,308 |
FINANCIAL INCOME, NET (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Financial expenses: | |||
| Bank charges and other | $ 495 | $ 443 | $ 730 |
| Interest on credit facility and amortization of debt issuance fees | 0 | 0 | 62 |
| Exchange rate expense, net | 4,796 | 0 | 0 |
| Total financial expenses | 5,291 | 443 | 792 |
| Financial income: | |||
| Exchange rate income, net | 0 | 361 | 4,687 |
| Interest income on deposits, money market funds and marketable securities | 60,659 | 41,993 | 18,659 |
| Accretion of discount on marketable securities | 132 | 0 | 0 |
| Total financial income | 60,791 | 42,354 | 23,346 |
| Financial income, net | $ 55,500 | $ 41,911 | $ 22,554 |
RELATED PARTIES (Narrative) (Details) - USD ($) $ in Thousands |
1 Months Ended | 12 Months Ended |
|---|---|---|
Aug. 31, 2024 |
Dec. 31, 2024 |
|
| Related Party Transactions [Abstract] | ||
| Charitable share contribution to Foundation | 68,000 | 68,000 |
| Fair value of charitable share contribution to foundation | $ 17,908 | |
| Donated amount | $ 6,300 | |
| Voting rights percentage | 14% |
SHAREHOLDERS' EQUITY (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||||
| Stockholders Equity Note [Line Items] | |||||||
| Share-based compensation cost | $ 147,117 | $ 100,186 | $ 104,920 | ||||
| Options granted | [1] | 32,802 | |||||
| Share-based compensation | $ 148,261 | $ 102,183 | $ 107,202 | ||||
| Percentage of ownership | 25.00% | ||||||
| Shares reserved for issuance under ESPP | 1,156,437 | 1,233,812 | 194,625 | ||||
| Shares reduce for issuance under ESPP | 778,500 | ||||||
| Ordinary shares repurchased under ESPP | 196,467 | ||||||
| Co-CEO | |||||||
| Stockholders Equity Note [Line Items] | |||||||
| Options granted | 22,481 | 74,108 | 73,074 | ||||
| 2017 share option plan | |||||||
| Stockholders Equity Note [Line Items] | |||||||
| Weighted-average grant-date fair value of options granted | $ 217.99 | $ 86.26 | $ 69.3 | ||||
| Intrinsic value of options exercised | $ 265,405 | $ 112,799 | $ 346,600 | ||||
| Unamortized share-based compensation expense | $ 146,335 | $ 118,311 | $ 107,411 | ||||
| Weighted average period for cost expected to be recognized | 1 year 9 months 3 days | 1 year 9 months | 1 year 9 months 14 days | ||||
| 2021 plan | |||||||
| Stockholders Equity Note [Line Items] | |||||||
| Number of ordinary shares reserved and available for grant and issuance | 8,941,243 | 7,847,149 | |||||
| Share reserve increased | 6,300,790 | ||||||
| Unrecognized compensation cost related to unvested restricted share units | $ 137,265 | $ 96,112 | $ 64,458 | ||||
| Weighted average period for cost expected to be recognized | 1 year 9 months 7 days | 1 year 9 months 18 days | 1 year 10 months 6 days | ||||
| 2024 Foundation plan | |||||||
| Stockholders Equity Note [Line Items] | |||||||
| Number of ordinary shares reserved and available for grant and issuance | 15,000 | 0 | |||||
| Restricted Stock Units (RSUs) | |||||||
| Stockholders Equity Note [Line Items] | |||||||
| Options granted | [2] | 824,855 | |||||
| Weighted-average grant-date fair value of options granted | [2] | $ 216.3 | |||||
| Restricted Stock Units (RSUs) | Co-CEO | |||||||
| Stockholders Equity Note [Line Items] | |||||||
| Options granted | 48,129 | 22,928 | |||||
| |||||||
SHAREHOLDERS' EQUITY (Details) - shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Class of Stock [Line Items] | |||
| Shares subject to the employee share purchase plan | 1,156,437 | 1,233,812 | 194,625 |
| Total | 64,050,412 | 62,299,717 | |
| Ordinary shares | |||
| Class of Stock [Line Items] | |||
| Ordinary shares reserved for future issuance | 50,773,337 | 48,923,903 | |
| Outstanding share options and RSUs | |||
| Class of Stock [Line Items] | |||
| Ordinary shares reserved for future issuance | 3,164,395 | 4,294,853 | |
| 2021 plan | |||
| Class of Stock [Line Items] | |||
| Shares available for future grants under the plan | 8,941,243 | 7,847,149 | |
| 2024 Foundation plan | |||
| Class of Stock [Line Items] | |||
| Shares available for future grants under the plan | 15,000 | 0 | |
SHAREHOLDERS' EQUITY (Details 1) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Number of Options outstanding | ||||
| Beginning balance | 3,079,252 | |||
| Granted | [1] | 32,802 | ||
| Exercised | (1,220,551) | |||
| Expired and forfeited | (123,273) | |||
| Ending balance | 1,768,230 | 3,079,252 | ||
| Exercisable | [1] | 1,403,701 | ||
| Weighted-Average Exercise Price | ||||
| Beginning balance | $ 48.82 | |||
| Granted | [1] | 0 | ||
| Exercised | 23.99 | |||
| Expired and forfeited | 79.84 | |||
| Ending balance | 62.9 | $ 48.82 | ||
| Exercisable | [1] | $ 53.66 | ||
| Weighted Average Remaining Contractual life, Outstanding | 6 years 14 days | 6 years 8 months 15 days | ||
| Weighted Average Remaining Contractual life, Exercisable | [1] | 5 years 8 months 19 days | ||
| Aggregate Intrinsic Value, outstanding | $ 305,379 | $ 435,699 | ||
| Aggregate Intrinsic Value, exercisable | [1] | $ 255,421 | ||
| ||||
SHAREHOLDERS' EQUITY (Details 2) |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Dec. 31, 2024
$ / shares
shares
| ||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward] | ||||||
| Granted | 32,802 | [1] | ||||
| Restricted Stock Units (RSUs) [Member] | ||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward] | ||||||
| Balance | 1,215,601 | |||||
| Granted | 824,855 | [2] | ||||
| Vested | (483,508) | |||||
| Canceled | (160,783) | |||||
| Balance | 1,396,165 | [2] | ||||
| Weighted-Average Fair Value | ||||||
| Balance | $ / shares | $ 134.41 | |||||
| Weighted-average fair value granted | $ / shares | 216.3 | [2] | ||||
| Weighted-average fair value vested | $ / shares | 142.35 | |||||
| Weighted-average fair value canceled | $ / shares | 154.56 | |||||
| Balance | $ / shares | $ 177.72 | [2] | ||||
| ||||||
SHAREHOLDERS' EQUITY (Details 3) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
| Share-based compensation, net of amounts capitalized | $ 147,117 | $ 100,186 | $ 104,920 |
| Capitalized share-based compensation costs | 1,144 | 1,997 | 2,282 |
| Total share-based compensation | 148,261 | 102,183 | 107,202 |
| Cost of revenues | |||
| Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
| Share-based compensation, net of amounts capitalized | 6,603 | 6,307 | 10,406 |
| Research and development | |||
| Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
| Share-based compensation, net of amounts capitalized | 50,995 | 38,737 | 32,957 |
| Sales and marketing | |||
| Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
| Share-based compensation, net of amounts capitalized | 33,865 | 25,395 | 33,457 |
| General and administrative | |||
| Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
| Share-based compensation, net of amounts capitalized | $ 55,654 | $ 29,747 | $ 28,100 |
INCOME TAXES (Narrative) (Details) $ in Thousands, ₪ in Billions |
12 Months Ended | |||
|---|---|---|---|---|
|
Dec. 31, 2024
ILS (₪)
|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2024
USD ($)
|
|
| Income Tax Disclosure [Abstract] | ||||
| Net operating loss carryforwards | $ | $ 207,569 | |||
| Corporate tax rate | 23.00% | 23.00% | 23.00% | |
| Tax rate for non-israeli subsidiaries | 21.00% | |||
| Threshold limit of consolidated revenues subject to tax rate on income derived from intellectual property | ₪ | ₪ 10 | |||
| Tax rate on income derived from intellectual property | 12.00% | |||
| Tax rate of development area | 7.50% | |||
| Minimum percentage of annual revenues derived from exports | 25.00% | |||
| Tax rate on dividends distributed from income from preferred technological enterprises | 20.00% | |||
| Tax rate on dividend distributed to foreign corporate shareholder | 4.00% | |||
| Maximum percentage of foreign investors defined for distribution of dividend to foreign corporate shareholder | 90.00% | |||
INCOME TAXES (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Income Tax Disclosure [Abstract] | |||
| Domestic (Israel) | $ 15,004 | $ (10,368) | $ (142,527) |
| Foreign | 19,462 | 13,694 | 13,066 |
| Income (loss) before income taxes | $ 34,466 | $ 3,326 | $ (129,461) |
INCOME TAXES (Details 1) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Income Tax Disclosure [Abstract] | |||
| Domestic (Israel) | $ 603 | $ 557 | $ 649 |
| Foreign | 1,491 | 4,646 | 6,757 |
| Total effective tax | $ 2,094 | $ 5,203 | $ 7,406 |
INCOME TAXES (Details 2) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Deferred tax assets: | ||
| Share-based compensation | $ 28,872 | $ 17,905 |
| Net operating loss carry forwards | 25,779 | 37,250 |
| Research and development | 2,457 | 4,398 |
| Reserves and allowances | 6,820 | 5,164 |
| Carryforward tax credits | 459 | 2,093 |
| Operating lease liabilities | 18,319 | 4,967 |
| Gross deferred tax assets | 82,706 | 71,777 |
| Valuation allowance | (62,227) | (62,719) |
| Net deferred tax assets | 20,479 | 9,058 |
| Deferred tax liabilities: | ||
| Property and equipment | (1,946) | (1,971) |
| Operating lease right-of-use assets | (15,383) | (5,469) |
| Deferred contract costs | (2,767) | (441) |
| Other | (383) | (1,177) |
| Deferred tax liabilities | (20,479) | (9,058) |
| Net deferred taxes | $ 0 | $ 0 |
INCOME TAXES (Details 3) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Tax | |||
| Theoretical tax benefit | $ 7,927 | $ 765 | $ (29,776) |
| Increase (decrease) in tax rate due to: | |||
| Taxes resulting from non-deductible expenses | 2,023 | 1,376 | 633 |
| Temporary differences for which no deferred taxes were created | 7,893 | 3,365 | 16,930 |
| Tax credits | (1,629) | (334) | 0 |
| Utilization of losses | (12,340) | (1,117) | 3,767 |
| Adjustment for previous years taxes | (838) | (523) | (161) |
| Preferred technological enterprise and the effect of different tax rates in other jurisdictions | (1,651) | 1,158 | 15,522 |
| Currency differences | 84 | (58) | (139) |
| Other | 625 | 571 | 630 |
| Total effective tax | $ 2,094 | $ 5,203 | $ 7,406 |
| Rate | |||
| Theoretical tax benefit | 23.00% | 23.00% | 23.00% |
| Taxes resulting from non-deductible expenses | 6.00% | 41.00% | 0.00% |
| Temporary differences for which no deferred taxes were created | 23.00% | 101.00% | (13.00%) |
| Tax credits | (5.00%) | (10.00%) | 0.00% |
| Utilization of losses | (36.00%) | (33.00%) | (3.00%) |
| Adjustment for previous years taxes | (2.00%) | (16.00%) | 0.00% |
| Preferred technological enterprise and the effect of different tax rates in other jurisdictions | (5.00%) | 35.00% | (12.00%) |
| Currency differences | 0.00% | (2.00%) | 0.00% |
| Other | 2.00% | 17.00% | (1.00%) |
| Effective tax | 6.00% | 156.00% | (6.00%) |
EARNINGS (LOSS) PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Numerator: | |||
| Net income (loss) attributable to ordinary shareholders, basic and diluted | $ 32,372 | $ (1,877) | $ (136,867) |
| Denominator: | |||
| Weighted-average ordinary shares outstanding, basic | 49,908,423 | 48,366,378 | 45,804,714 |
| Dilutive effect: | |||
| Employee share options, and RSUs | 2,512,403 | 0 | 0 |
| Weighted-average ordinary shares outstanding, diluted | 52,420,826 | 48,366,378 | 45,804,714 |
| Net income (loss) per share attributable to ordinary shareholders, basic | $ 0.65 | $ (0.04) | $ (2.99) |
| Net income (loss) per share attributable to ordinary shareholders, diluted | $ 0.62 | $ (0.04) | $ (2.99) |
SEGMENT REPORTING (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||
| Segment Reporting [Abstract] | |||||
| Total revenues | $ 971,995 | $ 729,695 | $ 519,029 | ||
| Share-based compensation | (129,209) | (100,186) | (104,920) | ||
| Charitable contribution to Foundation | (24,208) | 0 | 0 | ||
| Tax benefit related to share-based compensation | 2,486 | 3,392 | 1,431 | ||
| Other segment items | [1] | (788,692) | (634,778) | (552,407) | |
| Net income (loss) | $ 32,372 | $ (1,877) | $ (136,867) | ||
| |||||
SEGMENT REPORTING (Details 1) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Revenue, Major Customer [Line Items] | |||
| Total revenues | $ 971,995 | $ 729,695 | $ 519,029 |
| Segment revenue benchmark | Geographic concentration risk | |||
| Revenue, Major Customer [Line Items] | |||
| Total revenues | 971,995 | 729,695 | 519,029 |
| United States | Segment revenue benchmark | Geographic concentration risk | |||
| Revenue, Major Customer [Line Items] | |||
| Total revenues | 484,523 | 364,070 | 255,495 |
| EMEA | Segment revenue benchmark | Geographic concentration risk | |||
| Revenue, Major Customer [Line Items] | |||
| Total revenues | 209,851 | 157,134 | 111,854 |
| United Kingdom | Segment revenue benchmark | Geographic concentration risk | |||
| Revenue, Major Customer [Line Items] | |||
| Total revenues | 101,538 | 73,236 | 50,625 |
| Rest of the world | Segment revenue benchmark | Geographic concentration risk | |||
| Revenue, Major Customer [Line Items] | |||
| Total revenues | $ 176,083 | $ 135,255 | $ 101,055 |
SEGMENT REPORTING (Details 2) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Revenue, Major Customer [Line Items] | ||
| Property and equipment, net | $ 41,576 | $ 37,418 |
| Property and equipment | Geographic concentration risk | ||
| Revenue, Major Customer [Line Items] | ||
| Property and equipment, net | 136,279 | 99,698 |
| Israel | Property and equipment | Geographic concentration risk | ||
| Revenue, Major Customer [Line Items] | ||
| Property and equipment, net | 72,613 | 72,262 |
| United States | Property and equipment | Geographic concentration risk | ||
| Revenue, Major Customer [Line Items] | ||
| Property and equipment, net | 17,895 | 23,773 |
| United Kingdom | Property and equipment | Geographic concentration risk | ||
| Revenue, Major Customer [Line Items] | ||
| Property and equipment, net | 43,030 | 1,417 |
| Rest of the world | Property and equipment | Geographic concentration risk | ||
| Revenue, Major Customer [Line Items] | ||
| Property and equipment, net | $ 2,741 | $ 2,246 |